These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30700004)

  • 1. Overexpression of the Interferon-Inducible Isoform 4 of
    Herold N
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30700004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interferon-inducible isoform of NCOA7 inhibits endosome-mediated viral entry.
    Doyle T; Moncorgé O; Bonaventure B; Pollpeter D; Lussignol M; Tauziet M; Apolonia L; Catanese MT; Goujon C; Malim MH
    Nat Microbiol; 2018 Dec; 3(12):1369-1376. PubMed ID: 30478388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction.
    Khan H; Winstone H; Jimenez-Guardeño JM; Graham C; Doores KJ; Goujon C; Matthews DA; Davidson AD; Rihn SJ; Palmarini M; Neil SJD; Malim MH
    PLoS Pathog; 2021 Nov; 17(11):e1009820. PubMed ID: 34807954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.
    Aiken C
    J Virol; 1997 Aug; 71(8):5871-7. PubMed ID: 9223476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.
    Miyauchi K; Kim Y; Latinovic O; Morozov V; Melikyan GB
    Cell; 2009 May; 137(3):433-44. PubMed ID: 19410541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 entry in SupT1-R5, CEM-ss, and primary CD4+ T cells occurs at the plasma membrane and does not require endocytosis.
    Herold N; Anders-Ößwein M; Glass B; Eckhardt M; Müller B; Kräusslich HG
    J Virol; 2014 Dec; 88(24):13956-70. PubMed ID: 25253335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion.
    de la Vega M; Marin M; Kondo N; Miyauchi K; Kim Y; Epand RF; Epand RM; Melikyan GB
    Retrovirology; 2011 Dec; 8():99. PubMed ID: 22145853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.
    Yonezawa A; Cavrois M; Greene WC
    J Virol; 2005 Jan; 79(2):918-26. PubMed ID: 15613320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor.
    Chen J; Dang Q; Unutmaz D; Pathak VK; Maldarelli F; Powell D; Hu WS
    J Virol; 2005 Apr; 79(7):4140-9. PubMed ID: 15767415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the vacuolar H(+)-ATPase in animal virus entry.
    Pérez L; Carrasco L
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2595-606. PubMed ID: 7931146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HIV-1 Entry Process: A Stoichiometric View.
    Brandenberg OF; Magnus C; Regoes RR; Trkola A
    Trends Microbiol; 2015 Dec; 23(12):763-774. PubMed ID: 26541228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entry of rhabdoviruses into animal cells.
    Regan AD; Whittaker GR
    Adv Exp Med Biol; 2013; 790():167-77. PubMed ID: 23884591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of TSPAN9 in Alphavirus Entry and Early Endosomes.
    Stiles KM; Kielian M
    J Virol; 2016 May; 90(9):4289-97. PubMed ID: 26865714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.
    Robinson LR; Whelan SP
    J Virol; 2016 Jan; 90(7):3640-9. PubMed ID: 26792739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Productive infection of human immunodeficiency virus type 1 in dendritic cells requires fusion-mediated viral entry.
    Janas AM; Dong C; Wang JH; Wu L
    Virology; 2008 Jun; 375(2):442-51. PubMed ID: 18329684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of vif for optimal infectivity: functional difference between Vif and Nef.
    Akari H; Uchiyama T; Fukumori T; Iida S; Koyama AH; Adachi A
    J Gen Virol; 1999 Nov; 80 ( Pt 11)():2945-2949. PubMed ID: 10580056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral Entry Inhibitors Targeting Six-Helical Bundle Core against Highly Pathogenic Enveloped Viruses with Class I Fusion Proteins.
    Pu J; Zhou JT; Liu P; Yu F; He X; Lu L; Jiang S
    Curr Med Chem; 2022; 29(4):700-718. PubMed ID: 33992055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the TLDc domain of human NCOA7-AS.
    Arnaud-Arnould M; Tauziet M; Moncorgé O; Goujon C; Blaise M
    Acta Crystallogr F Struct Biol Commun; 2021 Aug; 77(Pt 8):230-237. PubMed ID: 34341188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and cellular biology of rhabdovirus entry.
    Belot L; Albertini A; Gaudin Y
    Adv Virus Res; 2019; 104():147-183. PubMed ID: 31439148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane Structure.
    Nieto-Garai JA; Glass B; Bunn C; Giese M; Jennings G; Brankatschk B; Agarwal S; Börner K; Contreras FX; Knölker HJ; Zankl C; Simons K; Schroeder C; Lorizate M; Kräusslich HG
    Front Immunol; 2018; 9():1983. PubMed ID: 30233582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.